Cite
MLA Citation
Jennifer Murillo et al.. “CTIM-08. A PILOT STUDY OF ABEMACICLIB WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS WITH LOSS OF CDKN2A/B OR GAIN OR AMPLIFICATION OF CDK4/6.” Neuro-oncology, vol. 24, n.d., p. vii61. http://access.bl.uk/ark:/81055/vdc_100169741862.0x000014